Physioneal + Dianeal + Extraneal + Nutrineal
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
ESRD
Conditions
ESRD, Diabetes, CAPD, APD
Trial Timeline
Jan 1, 2008 → Jul 1, 2011
NCT ID
NCT00567489About Physioneal + Dianeal + Extraneal + Nutrineal
Physioneal + Dianeal + Extraneal + Nutrineal is a approved stage product being developed by Baxter for ESRD. The current trial status is completed. This product is registered under clinical trial identifier NCT00567489. Target conditions include ESRD, Diabetes, CAPD.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00567489 | Approved | Completed |
Competing Products
17 competing products in ESRD
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Roxadustat | AstraZeneca | Phase 3 | 77 |
| Doravirine | Merck | Approved | 85 |
| MK-2060 + Placebo | Merck | Phase 1 | 33 |
| Induction therapy + Corticosteroids + EVR+rCNI + MPA+sCNI | Novartis | Approved | 85 |
| Mycophenolic Acid (Myfortic) | Novartis | Approved | 85 |
| Avacopan | Amgen | Phase 1 | 32 |
| [¹⁴C]Etelcalcetide | Amgen | Phase 1 | 32 |
| apixaban | Bristol Myers Squibb | Phase 2 | 51 |
| ISIS 416858 + Placebo | Bayer | Phase 2 | 49 |
| ISIS 416858 + Placebo | Bayer | Phase 2 | 49 |
| 10 GE Xenokidney | United Therapeutics | Phase 1/2 | 38 |
| GGTA1 KO Thymokidney | United Therapeutics | Phase 1/2 | 38 |
| Dianeal + Physioneal + Extraneal + Nutrineal | Baxter | Phase 3 | 74 |
| Dianeal + Dianeal, Extraneal, Nutrineal | Baxter | Phase 3 | 74 |
| Acellular Tissue Engineered Vessel (ATEV) | Humacyte | Phase 3 | 69 |
| Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate | Rockwell Medical | Phase 2 | 44 |
| soluble ferric pyrophosphate (SFP) | Rockwell Medical | Pre-clinical | 15 |